Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 231,737 | 162,855 | 257,914 | 260,119 | 252,854 |
| Marketable Securities | 138,820 | 136,593 | 136,186 | 139,095 | 305,541 |
| Receivables | 99,945 | 91,460 | 97,762 | 89,462 | 85,233 |
| Inventories | 31,598 | 34,443 | 36,543 | 37,476 | 36,927 |
| Other current assets | 0 | 45,508 | 0 | 0 | 0 |
| TOTAL | $518,445 | $481,868 | $539,835 | $537,290 | $688,871 |
| Non-Current Assets | |||||
| PPE Net | 25,921 | 7,904 | 24,833 | 22,283 | 22,708 |
| Intangibles | 1,287,690 | 797,992 | 1,408,644 | 1,755,531 | 1,706,813 |
| Other Non-Current Assets | 2,894 | 612,592 | 3,454 | 3,550 | 3,518 |
| TOTAL | $1,316,505 | $1,418,488 | $1,436,931 | $1,781,364 | $1,733,039 |
| Total Assets | $1,834,950 | $1,900,356 | $1,976,766 | $2,318,654 | $2,421,910 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 20,455 |
| Accounts payable and accrued liabilities | 17,371 | 7,717 | 8,511 | 8,154 | 7,591 |
| Accrued Expenses | 199,071 | 166,732 | 190,457 | 210,853 | 147,479 |
| Other current liabilities | 50,007 | 103,269 | 99,106 | 98,646 | 97,515 |
| TOTAL | $329,419 | $277,718 | $339,697 | $355,142 | $307,939 |
| Non-Current Liabilities | |||||
| Long Term Debt | 466,595 | 466,291 | 490,518 | 490,210 | 783,333 |
| Deferred Revenues | 42,510 | N/A | 41,623 | 37,489 | 34,899 |
| Other Non-Current Liabilities | 254,046 | 366,103 | 268,132 | 333,362 | 235,355 |
| TOTAL | $765,536 | $832,394 | $836,762 | $1,016,064 | $1,189,883 |
| Total Liabilities | $1,094,955 | $1,110,112 | $1,176,459 | $1,371,206 | $1,497,822 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,327 | 34,089 | 35,374 | 35,288 | 35,045 |
| Common Shares | 343 | 341 | 354 | 353 | 344 |
| Retained earnings | -530,921 | -477,817 | -481,277 | -329,215 | -315,150 |
| Other shareholders' equity | -4,362 | -3,908 | -3,637 | -3,633 | -3,746 |
| TOTAL | $739,995 | $790,244 | $800,307 | $947,448 | $924,088 |
| Total Liabilities And Equity | $1,834,950 | $1,900,356 | $1,976,766 | $2,318,654 | $2,421,910 |